Health Products

ONLINE DAT Amphetamines II for Roche Hitachi 917 and Modular P Analyzers, ONLINE DAT Amphetamines II For Cobas Integra and Amphetamines II (AMPS2) (2018-08-31)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
24047901B. ONLINE DAT Amphetamines II For Cobas Integra
Manufacturer
Roche Diagnostics GMBH
Sandhoferstrasse 116
Mannheim
68305
GERMANY
04512936190
24047201C. Amphetamines II (AMPS2)
Manufacturer
Roche Diagnostics GMBH
Sandhoferstrasse 116
Mannheim
68305
GERMANY
06334385190
26609801A. ONLINE DAT Amphetamines II for Roche Hitachi 917 and Modular P Analyzers
Manufacturer
Roche Diagnostics GMBH
Sandhoferstrasse 116
Mannheim
68305
GERMANY
04939425190

Introduction

Affected products

A. ONLINE DAT Amphetamines II for Roche Hitachi 917 and Modular P Analyzers
B. ONLINE DAT Amphetamines II For Cobas Integra
C. Amphetamines II (AMPS2)

Reason

A new cross reactivity was identified for the prodrug Lisdexamphetamin. As a consequence, the following statement will be added in the method sheets of all amphetamine assays: “Lisdexamphetamine is a pharmacologically inactive prodrug of D-Amphetamine. After oral ingestion, Lisdexamphetamine is converted to l-lysine and active D-Amphetamine which may cause a positive test result with this assay.”
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime